Dikmen Dokmeci
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dikmen Dokmeci has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Ozgur Gunduz
Department of Medical Pharmacology, Trakya University Faculty of Medicine, Edirne, Turkey
4 shared publications - Cetin Hakan Karadag
Department of Pharmacology, Trakya University School of Medicine, Edirne, Turkey
3 shared publications - Ahmet Ulugol
Department of Medical Pharmacology, Faculty of Medicine, Trakya University, Edirne, Turkey
2 shared publications - Ruhan Deniz Topuz
Department of Medical Pharmacology, Trakya University Faculty of Medicine , Edirne
2 shared publications Cem Uzal
Department of Radiation Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey
1 shared publicationFatma Nesrin Turan
Department of Biostatistics, Faculty of Medicine, Trakya University, Edirne, Turkey
1 shared publication
Latest Publications
- Open Access
- 2 March 2026
- Published by Springer Nature in Inflammopharmacology
- Vol. 34 (4) , 2567-2578
Effects of Pelargonium sidoides root extract on paw oedema, nitric oxide signaling, and synovial vascular changes in a rat model of adjuvant-induced arthritis
Rheumatoid arthritis (RA) is characterized by chronic synovitis with pannus formation and progressive joint destruction. Pannus growth relies on angiogenesis, and nitric oxide (NO) contributes to vascular and inflammatory signaling. Although Pelargonium sidoides (PS) has not been evaluated in experimental arthritis, prior work suggests that PS can modulate NO production in activated macrophages. Arthritis was induced with complete Freund’s adjuvant (CFA) on day 0. On day 17, rats with ≥ 5% paw swelling were treated. From day 17 to day 27, rats received daily oral P. sidoides (100, 200, or 500 mg/kg), ibuprofen (100 mg/kg), or vehicle. Paw diameter was recorded during treatment. On day 27, tissues were collected for histopathology (inflammation, angiogenesis, granuloma formation, synovial hyperplasia) and blood was analysed for nitrite/nitrate (NOx) and oxidative/antioxidant markers (asymmetric dimethylarginine (ADMA), malondialdehyde (MDA), superoxide dismutase (SOD), catalase, and glutathione). All doses of P. sidoides reduced paw oedema. The 200 mg/kg dose resulted in NOx levels and synovial microvessel densities that were numerically closer to healthy control values; however, these improvements did not reach statistical significance when compared directly to the vehicle group. Other oxidative markers showed no consistent changes. Plasma glutathione decreased across PS-treated groups without accompanying increases in MDA or body-weight loss, which is compatible with increased utilization during phytochemical clearance rather than overt systemic toxicity. In conclusion, P. sidoides improved macroscopic swelling in adjuvant arthritis and, at 200 mg/kg, showed numerical shifts toward control-like values in plasma NOx and synovial microvessel density, although studies with greater statistical power are needed to confirm these exploratory tissue-level signals.
- 2 March 2026
- Published by Springer Nature in Inflammopharmacology
- Vol. 34 (4) , 2567-2578
Open AccessEffects of Pelargonium sidoides root extract on paw oedema, nitric oxide signaling, and synovial vascular changes in a rat model of adjuvant-induced arthritis
Rheumatoid arthritis (RA) is characterized by chronic synovitis with pannus formation and progressive joint destruction. Pannus growth relies on angiogenesis, and nitric oxide (NO) contributes to vascular and inflammatory signaling. Although Pelargonium sidoides (PS) has not been evaluated in experimental arthritis, prior work suggests that PS can modulate NO production in activated macrophages. Arthritis was induced with complete Freund’s adjuvant (CFA) on day 0. On day 17, rats with ≥ 5% paw swelling were treated. From day 17 to day 27, rats received daily oral P. sidoides (100, 200, or 500 mg/kg), ibuprofen (100 mg/kg), or vehicle. Paw diameter was recorded during treatment. On day 27, tissues were collected for histopathology (inflammation, angiogenesis, granuloma formation, synovial hyperplasia) and blood was analysed for nitrite/nitrate (NOx) and oxidative/antioxidant markers (asymmetric dimethylarginine (ADMA), malondialdehyde (MDA), superoxide dismutase (SOD), catalase, and glutathione). All doses of P. sidoides reduced paw oedema. The 200 mg/kg dose resulted in NOx levels and synovial microvessel densities that were numerically closer to healthy control values; however, these improvements did not reach statistical significance when compared directly to the vehicle group. Other oxidative markers showed no consistent changes. Plasma glutathione decreased across PS-treated groups without accompanying increases in MDA or body-weight loss, which is compatible with increased utilization during phytochemical clearance rather than overt systemic toxicity. In conclusion, P. sidoides improved macroscopic swelling in adjuvant arthritis and, at 200 mg/kg, showed numerical shifts toward control-like values in plasma NOx and synovial microvessel density, although studies with greater statistical power are needed to confirm these exploratory tissue-level signals.
- 18 November 2020
- Published by S. Karger AG in Neuropsychobiology
- Vol. 80 (3) , 264-270
The Role of Hydrogen Sulfide in the Development of Tolerance and Dependence to Morphine in Mice
Objective: Hydrogen sulfide is an endogenous gaseous mediator that has been indicated to have a role in pain mechanisms. In this study, we aimed to detect brain and spinal cord hydrogen sulfide levels during different phases of tolerance and dependence to morphine and to determine the effects of inhibition of endogenous hydrogen sulfide production on the development of tolerance and dependence. Methods: Morphine tolerance and dependence was developed by subcutaneous injection of morphine (10 mg/kg) twice daily for 12 days. Physical dependence was determined by counting the jumps for 20 min, which is a withdrawal symptom occurring after a single dose of naloxone (5 mg/kg) administered intraperitoneally (i.p.). Propargylglycine (30 mg/kg, i.p.), a cystathionine-γ-lyase inhibitor, and hydroxylamine (12.5 mg/kg, i.p.), a cystathionine-β-synthase inhibitor, were used as hydrogen sulfide synthase inhibitors. The tail-flick and hot-plate tests were used to determine the loss of antinociceptive effects of morphine and development of tolerance. Results: It was found that chronic and acute uses of both propargylglycine and hydroxylamine prevented the development of tolerance to morphine, whereas they had no effect on morphine dependence. Chronic and acute administrations of hydrogen sulfide synthase inhibitors did not exert any difference in hydrogen sulfide levels in brain and spinal cords of both morphine-tolerant and -dependent animals. Conclusion: It has been concluded that hydrogen sulfide synthase inhibitors may have utility in preventing morphine tolerance.
- 18 November 2020
- Published by S. Karger AG in Neuropsychobiology
- Vol. 80 (3) , 264-270
The Role of Hydrogen Sulfide in the Development of Tolerance and Dependence to Morphine in Mice
Objective: Hydrogen sulfide is an endogenous gaseous mediator that has been indicated to have a role in pain mechanisms. In this study, we aimed to detect brain and spinal cord hydrogen sulfide levels during different phases of tolerance and dependence to morphine and to determine the effects of inhibition of endogenous hydrogen sulfide production on the development of tolerance and dependence. Methods: Morphine tolerance and dependence was developed by subcutaneous injection of morphine (10 mg/kg) twice daily for 12 days. Physical dependence was determined by counting the jumps for 20 min, which is a withdrawal symptom occurring after a single dose of naloxone (5 mg/kg) administered intraperitoneally (i.p.). Propargylglycine (30 mg/kg, i.p.), a cystathionine-γ-lyase inhibitor, and hydroxylamine (12.5 mg/kg, i.p.), a cystathionine-β-synthase inhibitor, were used as hydrogen sulfide synthase inhibitors. The tail-flick and hot-plate tests were used to determine the loss of antinociceptive effects of morphine and development of tolerance. Results: It was found that chronic and acute uses of both propargylglycine and hydroxylamine prevented the development of tolerance to morphine, whereas they had no effect on morphine dependence. Chronic and acute administrations of hydrogen sulfide synthase inhibitors did not exert any difference in hydrogen sulfide levels in brain and spinal cords of both morphine-tolerant and -dependent animals. Conclusion: It has been concluded that hydrogen sulfide synthase inhibitors may have utility in preventing morphine tolerance.
- Open Access
- 30 September 2019
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 44 (3) , 866-874
Dipiron farelerde anksiyolitik-benzeri etkiler oluşturuyor mu?
Amaç: Yakın zamanda parasetamol’ün anksiyolitik-benzeri etkileri olduğu ve bu etkilerine kannabinoid CB1 reseptörlerinin aracılık ettiği gösterilmiştir. Etkilerinde santral sinir sisteminin rolü olduğu uzun zamandır düşünülen ve etkileri açısından non-steroid anti-inflamatuvar ilaçlardan çok parasetamol ile benzerlik gösteren bir analjezik olan dipiron’un da antinosiseptif etkisinde kannabinoid sistemin rolü olduğu belirtilmiştir. Bu verilerden yola çıkarak dipiron’un anksiyolitik etki gösterebileceği düşünüldü; varsa bu etkisinde kannabinoid ve TRPV1 reseptörlerinin katkısının araştırılması planlandı.Gereç ve Yöntem: Balb-c farelerde dipiron (150, 300, 600 mg/kg, i.p.) verildikten sonra üç odalı sosyallik ve sosyal yenilik testi, açık alan testi ve yükseltilmiş artı labirent testleri uygulanması, etki görülürse kannabinoid CB1 antagonisti AM251 (1 mg/kg i.p.), CB2 antagonisti SR 144528 (1 mg/kg i.p.) ve TRPV1 antagonisti kapsazepin (3 mg/kg i.p.) ile birlikte verilmesi düşünüldü. Bulgular: Dipiron herhangi bir dozunda davranış testlerinin (üç odalı sosyallik ve sosyal yenilik testi, açık alan testi ve yükseltilmiş artı labirent testi) hiçbirisinde etki göstermedi. Bu nedenle, dipiron ile birlikte kannabinoid CB1, CB2 ve TRPV1 reseptör antagonistlerinin birlikte uygulanacağı aşamaya geçilmedi.Sonuç: Parasetamol’den farklı olarak, dipiron farelerde anksiyolitik-benzeri etkilere yol açmamaktadır. Deneysel modeller ve ölçüm yöntemlerindeki farklılıklar bu bulgularımızın nedeni olabilir.
- 30 September 2019
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 44 (3) , 866-874
Open AccessDipiron farelerde anksiyolitik-benzeri etkiler oluşturuyor mu?
Amaç: Yakın zamanda parasetamol’ün anksiyolitik-benzeri etkileri olduğu ve bu etkilerine kannabinoid CB1 reseptörlerinin aracılık ettiği gösterilmiştir. Etkilerinde santral sinir sisteminin rolü olduğu uzun zamandır düşünülen ve etkileri açısından non-steroid anti-inflamatuvar ilaçlardan çok parasetamol ile benzerlik gösteren bir analjezik olan dipiron’un da antinosiseptif etkisinde kannabinoid sistemin rolü olduğu belirtilmiştir. Bu verilerden yola çıkarak dipiron’un anksiyolitik etki gösterebileceği düşünüldü; varsa bu etkisinde kannabinoid ve TRPV1 reseptörlerinin katkısının araştırılması planlandı.Gereç ve Yöntem: Balb-c farelerde dipiron (150, 300, 600 mg/kg, i.p.) verildikten sonra üç odalı sosyallik ve sosyal yenilik testi, açık alan testi ve yükseltilmiş artı labirent testleri uygulanması, etki görülürse kannabinoid CB1 antagonisti AM251 (1 mg/kg i.p.), CB2 antagonisti SR 144528 (1 mg/kg i.p.) ve TRPV1 antagonisti kapsazepin (3 mg/kg i.p.) ile birlikte verilmesi düşünüldü. Bulgular: Dipiron herhangi bir dozunda davranış testlerinin (üç odalı sosyallik ve sosyal yenilik testi, açık alan testi ve yükseltilmiş artı labirent testi) hiçbirisinde etki göstermedi. Bu nedenle, dipiron ile birlikte kannabinoid CB1, CB2 ve TRPV1 reseptör antagonistlerinin birlikte uygulanacağı aşamaya geçilmedi.Sonuç: Parasetamol’den farklı olarak, dipiron farelerde anksiyolitik-benzeri etkilere yol açmamaktadır. Deneysel modeller ve ölçüm yöntemlerindeki farklılıklar bu bulgularımızın nedeni olabilir.
- 22 December 2012
- Published by AVES YAYINCILIK A.Ş. in Balkan Medical Journal
- Vol. 29 (4) , 358-363
The Protective Effect of Curcumin on Ionizing Radiation-induced Cataractogenesis in Rats
The aim of the study was to determine the protective effect of curcumin against ionizing radiation-induced cataract in the lens of rats. Rats were divided into six groups. Group 1: Control, Group 2: Dimethyl sulfoxide (DMSO), Group 3: DMSO+curcumin, Group 4: Irradiation, Group 5: Irradiation+DMSO, Group 6: Irradiation+DMSO+curcumin. A 15 Gy total dose was given to 4, 5, 6 groups for radiation damage. Curcumin (100 mg/kg) was dissolved in DMSO and given by intragastric intubation for 28 days. At the end of the experiment, lenses were graded and enucleated. The lenticular activity of the antioxidant enzymes, total antioxidant and glutathione peroxidase (GSH-Px), and the malondialdehyde (MDA) were measured. 100% Cataract was seen in the irradiation group. Cataract rate fell to 40% and was limited at grade 1 and 2 in the curcumin group. In the irradiation group, antioxidant enzyme levels were decreased, MDA levels were increased. There was an increase in antioxidant enzyme levels and a significant decrease in MDA in the group which was given curcumin. Curcumin has antioxidant and radioprotective properties and is likely to be a valuable agent for protection against ionizing radiation. Hence, it may be used as an antioxidant and radioprotector against radiation-induced cataractogenesis.
- 22 December 2012
- Published by AVES YAYINCILIK A.Ş. in Balkan Medical Journal
- Vol. 29 (4) , 358-363
The Protective Effect of Curcumin on Ionizing Radiation-induced Cataractogenesis in Rats
The aim of the study was to determine the protective effect of curcumin against ionizing radiation-induced cataract in the lens of rats. Rats were divided into six groups. Group 1: Control, Group 2: Dimethyl sulfoxide (DMSO), Group 3: DMSO+curcumin, Group 4: Irradiation, Group 5: Irradiation+DMSO, Group 6: Irradiation+DMSO+curcumin. A 15 Gy total dose was given to 4, 5, 6 groups for radiation damage. Curcumin (100 mg/kg) was dissolved in DMSO and given by intragastric intubation for 28 days. At the end of the experiment, lenses were graded and enucleated. The lenticular activity of the antioxidant enzymes, total antioxidant and glutathione peroxidase (GSH-Px), and the malondialdehyde (MDA) were measured. 100% Cataract was seen in the irradiation group. Cataract rate fell to 40% and was limited at grade 1 and 2 in the curcumin group. In the irradiation group, antioxidant enzyme levels were decreased, MDA levels were increased. There was an increase in antioxidant enzyme levels and a significant decrease in MDA in the group which was given curcumin. Curcumin has antioxidant and radioprotective properties and is likely to be a valuable agent for protection against ionizing radiation. Hence, it may be used as an antioxidant and radioprotector against radiation-induced cataractogenesis.